Joseph Prigg
Physician Assistant · Lewes, DENPI 1245233105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $766 and has fallen 92.0% since, to $62 in 2025. Among physician assistant clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$302
- Novo Nordisk$238
- GSK$223
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$206
- AstraZeneca$177
- Boehringer Ingelheim$165
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,359100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $302 |
| Novo Nordisk | 15 | $238 |
| GSK | 8 | $223 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $206 |
| AstraZeneca(2 entities) | 10 | $177 |
| Boehringer Ingelheim | 11 | $165 |
| AbbVie | 9 | $157 |
| Exact Sciences | 6 | $115 |
| Amgen(2 entities) | 7 | $111 |
| Astellas Pharma US Inc | 6 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $97 |
| Pfizer | 6 | $95 |
| Daiichi Sankyo Inc. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Bayer | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Lundbeck LLC | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Amarin Pharma, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Merck | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$119
How this compares
$2,359 in reported general payments places this provider in the 90th percentile of 527 physician assistant providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $65,969 |
| MounjaroTirzepatide | 24 | $47,659 |
| TrulicityDulaglutide | 31 | $42,484 |
| EliquisApixaban | 27 | $20,832 |
| JanuviaSitagliptin Phosphate | 13 | $20,459 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $18,883 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $16,888 |
| JanumetSitagliptin Phos/Metformin Hcl | 18 | $16,226 |
| OxycontinOxycodone Hcl | 33 | $16,067 |
| FetzimaLevomilnacipran Hcl | 12 | $5,651 |
| Atorvastatin Calcium | 376 | $5,492 |
| Rosuvastatin Calcium | 145 | $3,676 |
| Telmisartan | 47 | $3,184 |
| Omeprazole | 160 | $3,161 |
| Olmesartan Medoxomil | 121 | $3,130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $302 | $90,14255 claims |
| Novo NordiskOzempic | $238 | $65,96954 claims |
| MerckJanuvia, Janumet | $19 | $36,68431 claims |
| PfizerEliquis | $95 | $20,83227 claims |
| GSKTrelegy Ellipta | $223 | $16,88819 claims |
| AbbVieFetzima, Synthroid | $157 | $7,94442 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 527 physician assistant providers in Delaware.
Other physician assistant in Lewes
- Jennifer RahnLewes$13K
- Drew VenablesLewes$12K
- Morgan PopovichLewes$12K
- Bryan PepperLewes$5K
- Eugene IsaacLewes$4K
- Kelly YudtLewes$3K
- Kristina JohnsonLewes$3K
- James LustDover$30K
- Vi BanhNewark$12K
- Jason SaulWilmington$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.